BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31408709)

  • 41. Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin.
    Okumura N; Haneishi A; Terasawa F
    Clin Chim Acta; 2009 Mar; 401(1-2):119-23. PubMed ID: 19109936
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The monocyte cell surface is a unique site of autoantigen generation in rheumatoid arthritis.
    Thomas MA; Naik P; Wang H; Giles JT; Girgis AA; Kim SY; Johnson TP; Curran AM; Crawford JD; Jahanbani S; Bingham CO; Robinson WH; Na CH; Darrah E
    Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2304199121. PubMed ID: 38630712
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extracellular Proteome and Citrullinome of the Oral Pathogen Porphyromonas gingivalis.
    Stobernack T; Glasner C; Junker S; Gabarrini G; de Smit M; de Jong A; Otto A; Becher D; van Winkelhoff AJ; van Dijl JM
    J Proteome Res; 2016 Dec; 15(12):4532-4543. PubMed ID: 27712078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The rheumatoid arthritis synovial fluid citrullinome reveals novel citrullinated epitopes in apolipoprotein E, myeloid nuclear differentiation antigen, and β-actin.
    van Beers JJ; Schwarte CM; Stammen-Vogelzangs J; Oosterink E; Božič B; Pruijn GJ
    Arthritis Rheum; 2013 Jan; 65(1):69-80. PubMed ID: 23044660
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protein citrullination: inhibition, identification and insertion.
    Barasa L; Thompson PR
    Philos Trans R Soc Lond B Biol Sci; 2023 Nov; 378(1890):20220240. PubMed ID: 37778377
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predicting Citrullination Sites in Protein Sequences Using mRMR Method and Random Forest Algorithm.
    Zhang Q; Sun X; Feng K; Wang S; Zhang YH; Wang S; Lu L; Cai YD
    Comb Chem High Throughput Screen; 2017; 20(2):164-173. PubMed ID: 28029071
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
    Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA
    J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated levels of fibrinogen-derived endogenous citrullinated peptides in synovial fluid of rheumatoid arthritis patients.
    Raijmakers R; van Beers JJ; El-Azzouny M; Visser NF; Božič B; Pruijn GJ; Heck AJ
    Arthritis Res Ther; 2012 May; 14(3):R114. PubMed ID: 22584083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peptidylarginine deiminase and protein citrullination in prion diseases: strong evidence of neurodegeneration.
    Jang B; Ishigami A; Maruyama N; Carp RI; Kim YS; Choi EK
    Prion; 2013; 7(1):42-6. PubMed ID: 23022892
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Iguratimod inhibits protein citrullination and inflammation by downregulating NBCe2 in patients with rheumatoid arthritis.
    Peng T; Li B; Bi L; Zhang F
    Biomed Pharmacother; 2024 May; 174():116551. PubMed ID: 38636399
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Local Joint inflammation and histone citrullination in a murine model of the transition from preclinical autoimmunity to inflammatory arthritis.
    Sohn DH; Rhodes C; Onuma K; Zhao X; Sharpe O; Gazitt T; Shiao R; Fert-Bober J; Cheng D; Lahey LJ; Wong HH; Van Eyk J; Robinson WH; Sokolove J
    Arthritis Rheumatol; 2015 Nov; 67(11):2877-87. PubMed ID: 26227989
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis.
    Bang H; Egerer K; Gauliard A; Lüthke K; Rudolph PE; Fredenhagen G; Berg W; Feist E; Burmester GR
    Arthritis Rheum; 2007 Aug; 56(8):2503-11. PubMed ID: 17665451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microbial pathways to subvert host immunity generate citrullinated neoantigens targeted in rheumatoid arthritis.
    Gómez-Bañuelos E; Konig MF; Andrade F
    Curr Opin Struct Biol; 2022 Aug; 75():102423. PubMed ID: 35834948
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Citrullinated Inhibitor of DNA Binding 1 Is a Novel Autoantigen in Rheumatoid Arthritis.
    Ohara RA; Edhayan G; Rasmussen SM; Isozaki T; Remmer HA; Lanigan TM; Campbell PL; Urquhart AG; Lawton JN; Chung KC; Fox DA; Ruth JH
    Arthritis Rheumatol; 2019 Aug; 71(8):1241-1251. PubMed ID: 30861322
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis.
    Chang X; Yamada R; Sawada T; Suzuki A; Kochi Y; Yamamoto K
    Rheumatology (Oxford); 2005 Mar; 44(3):293-8. PubMed ID: 15561738
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The human peptidylarginine deiminases type 2 and type 4 have distinct substrate specificities.
    Assohou-Luty C; Raijmakers R; Benckhuijsen WE; Stammen-Vogelzangs J; de Ru A; van Veelen PA; Franken KL; Drijfhout JW; Pruijn GJ
    Biochim Biophys Acta; 2014 Apr; 1844(4):829-36. PubMed ID: 24594197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biological relevance of citrullinations: diagnostic, prognostic and therapeutic options.
    Gudmann NS; Hansen NU; Jensen AC; Karsdal MA; Siebuhr AS
    Autoimmunity; 2015 Mar; 48(2):73-9. PubMed ID: 25520183
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: identification and validation.
    Ytterberg AJ; Joshua V; Reynisdottir G; Tarasova NK; Rutishauser D; Ossipova E; Haj Hensvold A; Eklund A; Sköld CM; Grunewald J; Malmström V; Jakobsson PJ; Rönnelid J; Padyukov L; Zubarev RA; Klareskog L; Catrina AI
    Ann Rheum Dis; 2015 Sep; 74(9):1772-7. PubMed ID: 24817415
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages.
    Vossenaar ER; Radstake TR; van der Heijden A; van Mansum MA; Dieteren C; de Rooij DJ; Barrera P; Zendman AJ; van Venrooij WJ
    Ann Rheum Dis; 2004 Apr; 63(4):373-81. PubMed ID: 15020330
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peptidylarginine deiminase type 4: identification of a rheumatoid arthritis-susceptible gene.
    Yamada R; Suzuki A; Chang X; Yamamoto K
    Trends Mol Med; 2003 Nov; 9(11):503-8. PubMed ID: 14604829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.